Commercialization: Licensing & Commercialization
In today's emerging biofuels marketplace, first movers will enjoy a distinct competitive advantage, and Qteros can help you get ahead of the curve.
A key advantage to a licensing partnership with Qteros is the breadth and depth of the expertise behind it. We are committed to working closely with licensees, sharing our advanced microbiology and process engineering know-how to optimize their cellulosic production processes and design plans to achieve near-term, commercial-scale production.
Qteros' customers gain more than a license to our unique Consolidated Bioprocessing (CBP) platform. We provide our customers with a comprehensive Process Design Package (PDP) complete with the the Q Microbe® and Q Media, technology licenses, engineering know-how, and documentation required to construct and operate a commercial facility capable of producing cellulosic ethanol using our CBP platform and the Q Microbe®.
Our Process Design Package (PDP) provides licensees with the proprietary technology and know-how to construct and operate a commercial facility for converting biomass into cellulosic ethanol at the lowest cost.
To learn more about licensing opportunities with Qteros, please contact Mick Sawka, Vice President of Commercial Development, at msawka@qteros.com.
Foundational Patent for CBP:
Qteros, Inc., and the University of Massachusetts Amherst were issued U.S. Patent No. 7,682,811 titled "Systems and Methods for Producing Biofuels and Related Materials" describing the novel creation of products, including biofuels, through the fermentation of biomass by a unique, naturally-occurring anaerobic microorganism. Click here to read the full press release. This patent serves as one of several foundational patents for Qteros' broad and international IP portfolio.